NEW YORK (TheStreet) -- Nanosphere (NSPH - Get Report) surged Wednesday after the molecular diagnostics company announced it has received FDA clearance for the bacterial portion of its Verigene Enteric Pathogens Nucleic Acid Test.
The company has completed clinical studies for the entire panel, including two more viral targets, and expects clearance of the full EP panel.
The stock was up 14.8% to $1.63 at 2:10 p.m. More than 6.1 million shares had changed hands, compared to the average volume of 833,709.
Must Read: Warren Buffett's 25 Favorite StocksSTOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts